Quest Diagnostics Incorporated reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 2,453 million compared to USD 2,550 million a year ago. Net income was USD 234 million compared to USD 631 million a year ago. Basic earnings per share from continuing operations was USD 2 compared to USD 5.05 a year ago. Diluted earnings per share from continuing operations was USD 1.96 compared to USD 4.96 a year ago.
For the six months, sales was USD 5,064 million compared to USD 5,270 million a year ago. Net income was USD 589 million compared to USD 1,100 million a year ago. Basic earnings per share from continuing operations was USD 4.97 compared to USD 8.52 a year ago. Diluted earnings per share from continuing operations was USD 4.88 compared to USD 8.38 a year ago.